Health Care & Life Sciences » Biotechnology | Kolon Life Science Inc.

Kolon Life Science Inc. | Mutual Funds

Mutual Funds that own Kolon Life Science Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
103,597
0.91%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
86,555
0.76%
0
0.01%
09/05/2018
66,153
0.57%
0
1.21%
09/06/2018
Vanguard Developed Markets Index Fund
39,980
0.35%
0
0%
07/31/2018
DFA Emerging Markets Core Equity Portfolio
25,294
0.22%
0
0.01%
04/30/2018
Government Pension Fund - Global (The)
23,461
0.21%
17,677
0%
12/31/2017
Vanguard FTSE All World (ex-US) Small Cap
20,849
0.18%
3,998
0.02%
07/31/2018
Mirae Asset TIGER Health Care ETF
14,964
0.13%
3,587
0.72%
04/30/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
12,775
0.11%
0
0.01%
09/05/2018
RAM (Lux) Systematic Funds - Emerging Markets Equities
10,727
0.09%
10,727
0.03%
06/30/2017

About Kolon Life Science

View Profile
Address
7th Floor, Kolon Tower Annex
Gwacheon-si GY 13837
Korea, Republic Of
Employees -
Website http://www.kolonls.co.kr
Updated 09/14/2018
KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. It operates through the Pharmaceuticals and Environment Businesses. The Pharmaceutical business provides cell and gene therapeutics.